XRP is once again gaining attention not only in the markets but also among institutional investors. Quantum Biopharma added 100,000 XRP to its crypto treasury, highlighting the growing trend of institutional adoption of cryptocurrencies.
Institutional Investment in XRP
According to lawyer Bill Morgan, Quantum Biopharma increased its crypto treasury by 100,000 XRP. This investment showcases companies' approach to diversifying their assets in the crypto space, where Quantum already holds Bitcoin, Solana, and Dogecoin.
Comparison with Bitcoin
Morgan also pointed out Quantum's decision to invest across multiple blockchains, challenging Bitcoin maximalists. He noted that companies are making choices based on analysis, unlike crypto enthusiasts who often dismiss other assets without substantial financial justification.
Current Trends and Technical Analysis of XRP
In the last 24 hours, XRP surged nearly 7% to $2.31. However, amidst this, long liquidations reached $9.27 million against $6.46 million of shorts. It's important to note that the RSI indicates 49, suggesting a lack of strong momentum. Breaking key resistance levels may significantly impact its price in the coming days.
XRP continues to remain in focus both for institutional investors and traders. Success in overcoming key resistance levels could greatly influence its price in the near future.
